Nath Bio-Genes (India) Limited
Share Price Target & Analysis

NSE:NATHBIOGEN

169.18

VWAP

174

Open

171.66

Close

174.04

High

167.32

Low

238.69

52 Week High

169.10
-2.56 (-1.49%)

NATHBIOGEN

(PHARMA)
38.2% Momentum

Turnaround Potential

126.15

52 Week Low

28.6

EPS

11.1

PE

0.46

PB

Deluxe
Quality

Iron
Valuation

#Analysis

NSE: NATHBIOGEN Share Price Financial Analysis & Valuation

Nath Bio-Genes (India) Limited (NATHBIOGEN) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical. It is one of Micro Cap company with Market Capitalization of Rs 496 (in Cr). Total number of free float shares are 1.9 (in Lacs). Nath Bio-Genes (India) Limited is listed on NSE with Exchange ID - INE448G01010 and trading code is NSE:NATHBIOGEN with short name Nath Bio-Genes.

In the past 1 year, Nath Bio-Genes (India) Limited has declared an equity dividend of Rs 2 per share. At the current share price of NATHBIOGEN at Rs 169.10, this results in a dividend yield of 1.18 %.

As per the Fundamental Analysis of NSE:NATHBIOGEN, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine NATHBIOGEN underlying value and future prospects. All of this data is available in NATHBIOGEN financial statements.

Quality of the Stock: As per the fundamental analysis of NSE:NATHBIOGEN, it is clearly understood that NATHBIOGEN is Deluxe performer in terms of earnings and profit margins with an EPS of 28.6. NSE:NATHBIOGEN book value per share as of today is 365.45. The current price to book ratio for NATHBIOGEN as of Apr 25, 2026 is 0.46.

Valuation of the Stock: The current valuation of NATHBIOGEN stock is like Iron which means currently the stock is Inexpensive. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of NATHBIOGEN whether to BUY this stock at current valuation. The delivery percentage of NATHBIOGEN is 70.47% is very crucial parameter which shows that 70.47% investors are anticipating that the price of NATHBIOGEN share should go up with VWAP at 169.18.

Now, the main question is whether to BUY or SELL, NSE:NATHBIOGEN at current valuation.
As per latest Analysis No. #1004:-

STRONG BUY NATHBIOGEN if All Greens

BUY NATHBIOGEN (at Lower Levels) if any 2 Greens

NEUTRAL or HOLD NATHBIOGEN (With Stop Loss) if only 1 Green

SELL NATHBIOGEN if NO Green Indicator

NSE: NATHBIOGEN Share Price Today (Apr 25, 2026)

(Nath Bio-Genes (India) Limited Daily Analysis on the basis of NATHBIOGEN Intraday Graph & Trend)

Nath Bio-Genes (India) Limited share price moved Down by -1.49% from its previous close of Rs 171.66. NATHBIOGEN stock last traded price is 169.10. NATHBIOGEN share price trend is Down with a total of 12908 stocks traded till now. It has touched an intraday high of Rs 174.04 and an intraday low of Rs 167.32. The NATHBIOGEN trading at 169.10, Down by Rs. -2.56, or -1.49 percent which suggests that most of the Traders are anticipating that the price of NATHBIOGEN share should go Down.

NSE: NATHBIOGEN Share Price Tomorrow Prediction

(Nath Bio-Genes (India) Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of NATHBIOGEN)

Nath Bio-Genes (India) Limited share price moved Down by -1.49%. NATHBIOGEN share price short term trend is Down. It suggests that NATHBIOGEN Share Price for Tomorrow remains the same with VWAP at 169.18 will be treated as stop loss for intraday traders. Nath Bio-Genes (India) Limited Long term investors can follow the NATHBIOGEN long term trend as mentiond in future forecast table.

NSE Code

NSE: NATHBIOGEN

NATHBIOGEN Share Price Today

169.10

NATHBIOGEN Share Price Target Prediction for 2026 ^

132.3 - 201.9

NATHBIOGEN Share Price Target Prediction for 2027*^

201.9 - 272.7

NATHBIOGEN Share Price Target Prediction for 2028*^

272.7 - 292.8

NATHBIOGEN Share Price Target Prediction for 2029*^

307

NATHBIOGEN Share Price Target Prediction for 2030*^

317

NATHBIOGEN Share Price Target Prediction for 2035*^

347
NATHBIOGEN Current Book Value 2025
363.6

*Nath Bio-Genes (India) Limited Short Term & Long Term share price target is based on current financial year earings of the company.

^NATHBIOGEN share price target prediction for 2025 2026 2027 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.

NATHBIOGEN Technical Analysis

Candlestick Pattern: @229.67

NATHBIOGEN Moving Averages

BUY (14) NEUTRAL (0) SELL (0)
MA Simple Action S1 Expo Action E2
MA_5 228.72 BUY 226.75 BUY
MA_12 216.66 BUY 218.63 BUY
MA_20 211.62 BUY 213.54 BUY
MA_32 204.01 BUY 205.45 BUY
MA_50 195.33 BUY 198.46 BUY
MA_100 177.67 BUY 189.4 BUY
MA_200 182.32 BUY 187.26 BUY

NATHBIOGEN Trend Oscillators

BUY (4) NEUTRAL (0) SELL (0)
Trend Oscillators Value Action
Bollinger Bands 211.62 Uptrend
MACD 1.62 BUY
ADX 38.77 Strong Trend
DMI (+/-) 28.03 / 15.85 Uptrend

NATHBIOGEN Momentum Oscillators

BUY (4) NEUTRAL (7) SELL (1)
Momentum Oscillators Value Action
RSI 68.15 Neutral
STOCHASTIC_K (Fast) 59.91 Neutral
STOCHASTIC_D (Slow) 72.51 Neutral
CCI 86 Neutral
PSAR 213.91 BUY
TRUE RANGE 12 BUY
ATR 8.96 BUY
WILLIAMS R -23.31 Neutral
TRIX 0 Neutral
STOCHASTIC RSI K 17.14 Oversold
STOCHASTIC RSI D 39.05 Neutral
MOMENTUM 23.87 BUY

NATHBIOGEN Last 1 Year Trend

Duration Value
1 Year -9.5%
3 Months 54.7%
1 Month 11.6%
1 Week 6.43%

NATHBIOGEN Technical Analysis Summary

Updated on 2025-07-11
Action Overall (%)
BUY 73%
NEUTRAL / HOLD 23%
SELL 3%

Most popular Questions & Answers about NATHBIOGEN


Nath Bio-Genes (India) Limited stock last traded price is 169.10. NATHBIOGEN share price moved Down by -1.49% from its previous close of Rs 171.66.

Nath Bio-Genes (India) Limited share price trend is Down with a total of 12908 stocks traded till now. It has touched an intraday high of Rs 256.38845 and an intraday low of Rs 167.32. The NATHBIOGEN trading at 169.10, Down by Rs. -2.56, or -1.49 percent which suggests that most of the Traders are anticipating that the price of NATHBIOGEN share should go Down and the Stop Loss will be around 169.18.

The market cap of Nath Bio-Genes (India) Limited is ₹496 (in Cr) as of Apr 24, 2026.

The current price to earning ratio for Nath Bio-Genes (India) Limited as of Apr 24, 2026 is 11.1.

The current price to book ratio for Nath Bio-Genes (India) Limited as of Apr 24, 2026 is 0.46.

The highest price of Nath Bio-Genes (India) Limited stock is ₹238.69 in the last 52-week.

The lowest price of Nath Bio-Genes (India) Limited stock is ₹126.15 in the last 52-week.

Nath Bio-Genes (India) Limited share trading at ₹169.10, Down by Rs. -2.56, or -1.49 percent which suggests that most of the traders are anticipating that the price of NATHBIOGEN share should go Down.

In 2025, Stock price target for Nath Bio-Genes (India) Limited (NATHBIOGEN) are ₹132.3 on downside and ₹201.9 on upside. Nath Bio-Genes (India) Limited share price target is based on current financial year earings of the company.

In 2026, Stock price target for Nath Bio-Genes (India) Limited (NATHBIOGEN) are ₹201.9 on downside and ₹272.7 on upside. Nath Bio-Genes (India) Limited share price target is based on forecasted future earnings of the company.

In 2027, Stock price target for Nath Bio-Genes (India) Limited (NATHBIOGEN) are ₹272.7 on downside and ₹292.8 on upside. Nath Bio-Genes (India) Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.

In next five years, Stock price target for Nath Bio-Genes (India) Limited (NATHBIOGEN) will be around ₹317 Nath Bio-Genes (India) Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of NATHBIOGEN.

The price of Nath Bio-Genes (India) Limited (NATHBIOGEN) shares moved by -1.49%. The short-term trend for NATHBIOGEN share price is Down. It implies that the share price of NATHBIOGEN will stay the same tomorrow and that intraday traders should treat VWAP at 169.18 as a stop loss. Investors with a long-term outlook can track NATHBIOGEN long-term trajectory, which is indicated in the future forecast table.

Estimated DCF Value of NATHBIOGEN stock is 342.9. Compared to the current market price of 169.10 INR, the NATHBIOGEN stock is Undervalued by 50.7%.

As per the fundamental analysis of Nath Bio-Genes (India) Limited (NATHBIOGEN), it is of Deluxe quality in terms of earnings and profit margins with an EPS of 28.6. Nath Bio-Genes (India) Limited book value per share as of today is 365.45. The current price to book ratio for NATHBIOGEN as of Apr 25, 2026 is 0.46.


NSE:NATHBIOGEN News & Other Useful Information about NATHBIOGEN Share Price


Peer Comparison of NSE: NATHBIOGEN

The Peers list includes companies operating in the same industry and having comparable market cap.

Sector: Pharmaceuticals

Company Price EPS BV
SUNPHARMA 1620.40 16.77 102.19
DIVISLAB 6361.50 94.85 600.79
MEDICAMEQ 257.66 6.52 202.47
CIPLA 1295.00 57.14 419.19
DRREDDY 1317.10 55.59 378.64
PGHH 5215.00 189.8 373.34
TORNTPHARM 4117.20 64.97 266.87
BIOCON 349.85 0.05 99.01
LUPIN 2296.10 120.18 611.19
ALKEM 5235.00 195.87 1194.91
Updated at: 24 Apr 2026 15:40

Feel free to contact us, in case of any queries.

SITEMAP 7331
Disclaimer: Published information or data available on the Website may not be current or up to date and also any information or data available on this website may contain inaccuracies and/or typographical errors. Kindly refer any reliable source for its accuracy. If you select any of these stocks for your trades, you do so at your own risk.

Stocks to Watch Today


ADANIENT 2287.60 -12.40 (-0.54%) | ADANIGREEN 1235.80 21.65 (1.78%) | ADANIPORTS 1585.10 -17.80 (-1.11%) | ADANITRANS 988.50 0.35 (0.04%) | AMBUJACEM 451.20 0.80 (0.18%) | APOLLOHOSP 7732.50 -48.50 (-0.62%) | ASIANPAINT 2485.10 -36.30 (-1.44%) | ATGL 626.85 5.15 (0.83%) | AUROPHARMA 1413.80 -21.60 (-1.5%) | AXISBANK 1365.90 -3.70 (-0.27%) | BAJAJ-AUTO 9576.00 25.50 (0.27%) | BAJAJFINSV 1770.70 -21.90 (-1.22%) | BAJFINANCE 921.55 3.20 (0.35%) | BALKRISIND 2225.40 -40.00 (-1.77%) | BANDHANBNK 174.67 0.77 (0.44%) | BANKBARODA 274.13 -2.21 (-0.8%) | BEL 444.45 -5.50 (-1.22%) | BERGEPAINT 460.40 -8.25 (-1.76%) | BHARTIARTL 1814.50 -26.70 (-1.45%) | BIOCON 349.85 -8.15 (-2.28%) | BOSCHLTD 36690.00 -690.00 (-1.85%) | BPCL 308.10 -1.70 (-0.55%) | BRITANNIA 5730.50 59.00 (1.04%) | CADILAHC 905.25 2.35 (0.26%) | CIPLA 1295.00 -10.90 (-0.83%) | COALINDIA 456.00 5.35 (1.19%) | COLPAL 2171.30 21.10 (0.98%) | DABUR 451.10 -8.90 (-1.93%) | DIVISLAB 6361.50 -17.00 (-0.27%) | DLF 587.05 -5.75 (-0.97%) | DMART 4443.50 -77.70 (-1.72%) | DRREDDY 1317.10 -13.90 (-1.04%) | EICHERMOT 7111.50 19.00 (0.27%) | GAIL 165.61 0.65 (0.39%) | GLAND 1713.50 -81.90 (-4.56%) | GODREJCP 1089.90 -53.05 (-4.64%) | GRASIM 2739.30 4.30 (0.16%) | GUJGASLTD 383.85 -2.15 (-0.56%) | HAVELLS 1238.60 -21.70 (-1.72%) | HCLTECH 1203.20 -74.40 (-5.82%) | HDFC 2724.30 0.00 (0%) | HDFCAMC 2735.00 26.80 (0.99%) | HDFCBANK 784.85 0.50 (0.06%) | HDFCLIFE 588.20 -10.45 (-1.75%) | HEROMOTOCO 4961.50 -70.50 (-1.4%) | HINDALCO 1048.35 7.00 (0.67%) | HINDUNILVR 2327.30 -39.10 (-1.65%) | HINDZINC 588.50 -3.60 (-0.61%) | ICICIBANK 1326.20 -21.80 (-1.62%) | ICICIGI 1772.10 -37.80 (-2.09%) | ICICIPRULI 514.20 -21.10 (-3.94%) | INDIGO 4523.10 -32.90 (-0.72%) | INDUSINDBK 847.95 -12.40 (-1.44%) | INDUSTOWER 402.20 -2.50 (-0.62%) | INFY 1154.60 -86.00 (-6.93%) | IOB 35.01 -0.13 (-0.37%) | IOC 143.47 -2.01 (-1.38%) | ITC 301.60 -3.70 (-1.21%) | JSWSTEEL 1255.70 -1.30 (-0.1%) | KOTAKBANK 370.85 0.45 (0.12%) | LT 4014.30 -39.80 (-0.98%) | LTI 5706.50 -337.50 (-5.58%) | LUPIN 2296.10 -45.30 (-1.93%) | M&M 3038.40 -9.30 (-0.31%) | MARICO 783.30 4.40 (0.56%) | MARUTI 13048.00 -112.00 (-0.85%) | MCDOWELL-N 1358.10 -8.00 (-0.59%) | MOTHERSUMI 121.00 -1.62 (-1.32%) | MUTHOOTFIN 3493.50 -67.90 (-1.91%) | NAUKRI 984.95 -33.10 (-3.25%) | NESTLEIND 1421.30 10.80 (0.77%) | NMDC 89.29 1.98 (2.27%) | NTPC 401.85 -0.40 (-0.1%) | ONGC 284.80 -1.45 (-0.51%) | PEL 1124.20 0.00 (0%) | PIDILITIND 1394.30 -7.80 (-0.56%) | PIIND 3081.20 11.60 (0.38%) | PNB 113.09 0.38 (0.34%) | POWERGRID 316.40 -2.75 (-0.86%) | RELIANCE 1327.80 -15.60 (-1.16%) | SAIL 178.46 2.01 (1.14%) | SBICARD 670.30 -10.25 (-1.51%) | SBILIFE 1768.90 -59.20 (-3.24%) | SBIN 1101.10 6.85 (0.63%) | SHREECEM 24950.00 -520.00 (-2.04%) | SIEMENS 3808.90 -55.50 (-1.44%) | SRF 2493.60 -48.80 (-1.92%) | SUNPHARMA 1620.40 -59.70 (-3.55%) | TATACONSUM 1174.00 -10.40 (-0.88%) | TATAMOTORS 375.45 3.40 (0.91%) | TATAMTRDVR 768.65 33.35 (4.54%) | TATASTEEL 210.07 -0.84 (-0.4%) | TCS 2396.90 -124.90 (-4.95%) | TECHM 1358.50 -63.00 (-4.43%) | TITAN 4410.00 -46.50 (-1.04%) | TORNTPHARM 4117.20 -30.00 (-0.72%) | ULTRACEMCO 11998.00 -169.00 (-1.39%) | UPL 631.40 -10.65 (-1.66%) | VEDL 720.95 -14.65 (-1.99%) | WIPRO 199.36 -3.40 (-1.68%) |